(Q42258464)

English

Dose-response relationships of perphenazine in the treatment of acute psychoses

scientific article published on January 1982

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Dose-response relationships of perphenazine in the treatment of acute psychoses (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

author name string

L B Hansen

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

N E Larsen

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

N Gulmann

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

publication date

1 January 1982

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

78

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

112-115

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Determination of perphenazine and itssulphoxide metabolite olite in human plasma after therapeutic doses by gas chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/6817364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma Level Monitoring of Antipsychotic Drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/6817364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood levels of thioridazine and some of its metabolites in psychiatric patients. A preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/6817364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic Criteria for Use in Psychiatric Research

1 reference

https://pubmed.ncbi.nlm.nih.gov/6817364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma concentrations of perphenazine and its sulphoxide metabolite during continuous oral treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/6817364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma levels of perphenazine (Trilafon) related to development of extrapyramidal side effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/6817364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of Thioxanthenes in Plasma at Therapeutic Concentrations

1 reference

https://pubmed.ncbi.nlm.nih.gov/6817364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radioimmunoassay for fluphenazine in human plasma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6817364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rating scale for extrapyramidal side effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/6817364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00432245

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42258464&oldid=2205174780"